Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 09, 2012 16:43 ET | Source: BioSyent Inc.

BioSyent Pharma Launches Cathejell(TM) Jelly 2%; Shipments to Commence May 2012

TORONTO, ONTARIO--(Marketwire - May 9, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that its subsidiary BioSyent Pharma Inc. has launched Cathejell™...
March 29, 2012 08:00 ET | Source: BioSyent Inc.

BioSyent Releases Fiscal 2011 and Fourth Quarter Financial Results-Strong Growth Continues

TORONTO, ONTARIO--(Marketwire - March 29, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its Fiscal 2011 and Fourth Quarter (Q4) 2011 financial results. ...
February 15, 2012 18:28 ET | Source: BioSyent Inc.

BioSyent Named to the TSX Venture Top 50(R) Ranking

MISSISSAUGA, ONTARIO--(Marketwire - Feb. 15, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) announced today that it has been named as one of the 2012 TSX Venture Top 50 companies. ...
December 15, 2011 17:48 ET | Source: BioSyent Inc.

BioSyent Announces Appointment of New Director

MISSISSAUGA, ONTARIO--(Marketwire - Dec. 15, 2011) - The Board of Directors of BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce the appointment of Paul R. Montador to...
November 15, 2011 16:00 ET | Source: BioSyent Inc.

BioSyent Releases Third Quarter 2011 Financial Results-Pharma Sales More Than Triple; YTD Sales Growth 73%

MISSISSAUGA, ONTARIO--(Marketwire - Nov. 15, 2011) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its Third Quarter (Q3) 2011 financial results. Total...
August 24, 2011 16:00 ET | Source: BioSyent Inc.

BioSyent Releases Second Quarter 2011 Financial Results-Pharma Sales Triple; Total Sales Growth 123%

MISSISSAUGA, ONTARIO--(Marketwire - Aug. 24, 2011) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its Second Quarter (Q2) 2011 financial results. Total...
July 28, 2011 16:48 ET | Source: BioSyent Inc.

BioSyent Pharma Receives Health Canada Approval for New In-Licensed Topical Anesthetic

MISSISSAUGA, ONTARIO--(Marketwire - July 28, 2011) - BioSyent Inc. (TSX VENTURE:RX) ("BioSyent") announces that its subsidiary BioSyent Pharma Inc. together with its manufacturing partner...
June 27, 2011 16:08 ET | Source: BioSyent Inc.

BioSyent Releases First Quarter 2011 Financial Results-Strong Growth Continues, Sales Increase 54%

MISSISSAUGA, ONTARIO--(Marketwire - June 27, 2011) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its First Quarter (Q1) 2011 financial results. These results have been...
April 13, 2011 16:00 ET | Source: BioSyent Inc.

BioSyent Releases 2010 Third Quarter Financial Results-Revised

MISSISSAUGA, ONTARIO--(Marketwire - April 13, 2011) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) has filed revised financial statements for the third quarter ending September 30, 2010 to include a...
March 14, 2011 18:00 ET | Source: BioSyent Inc.

BioSyent Releases Fiscal and Q4 2010 Financial Results

MISSISSAUGA, ONTARIO--(Marketwire - March 14, 2011) - BioSyent Inc. ("BioSyent")(TSX VENTURE:RX) today released a summary of its 2010 financial results. Total Sales were...